ArticleMolecular therapy : the journal of the American Society of Gene Therapy2018

PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts.

David C Bishop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.